{"text": ["10", "Smart", "Dividend", "Stocks", "for", "the", "Rest", "of", "the", "Year"], "created_at": "2019-06-11 19:15:22"}
{"text": ["Roche's", "Polivy", "Gets", "FDA", "Nod,", "Gazyva", "Meets", "Goals", "in", "Phase", "II"], "created_at": "2019-06-11 16:11:52"}
{"text": ["Roche's", "Polivy", "Gets", "FDA", "Nod,", "Gazyva", "Meets", "Goals", "in", "Phase", "II"], "created_at": "2019-06-11 16:11:52"}
{"text": ["Roche's", "Polivy", "Gets", "FDA", "Nod,", "Gazyva", "Meets", "Goals", "in", "Phase", "II"], "created_at": "2019-06-11 13:54:01"}
{"text": ["Lilly", "Announces", "Tradjenta", "Cardiovascular", "Outcome", "Study", "Data"], "created_at": "2019-06-11 13:03:01"}
{"text": ["New", "Two-Year", "Data", "at", "the", "24th", "World", "Congress", "of", "Dermatology", "Shows", "SKYRIZI\u2122", "(risankizumab)", "Maintains", "Complete", "Skin", "Clearance"], "created_at": "2019-06-11 11:00:00"}
{"text": ["AbbVie-", "Unique", "Mix", "of", "Growth,", "Income", "", "Value"], "created_at": "2019-06-11 10:00:00"}
{"text": ["Horseman", "Capital", "Management\u2019s", "Return,", "AUM,", "and", "Holdings"], "created_at": "2019-06-11 05:39:17"}
